Literature DB >> 23948014

An assessment of the performance of self-reported vaccination status for hepatitis B, National Health and Nutrition Examination Survey 1999-2008.

Maxine M Denniston1, Kathy K Byrd, R Monina Klevens, Jan Drobeniuc, Saleem Kamili, Ruth B Jiles.   

Abstract

OBJECTIVES: We sought to assess the performance of self-reported vaccination with hepatitis B vaccine (HepB) compared with serological status for hepatitis B markers in the general US civilian population.
METHODS: Using 1999 through 2008 National Health and Nutrition Examination Survey data, we calculated 3 measures of agreement between self-reported HepB vaccination status and serological status: percent concordance, and positive (PPV) and negative predictive values (NPV) of self-report. Logistic regression was used to identify factors associated with agreement between self-report and serological status.
RESULTS: Overall agreement was 83% (95% CI = 82.3, 83.7), NPV of self-report was high (0.95; 95% CI = 0.93, 0.95) and PPV was low (0.53; 95% CI = 0.51, 0.54). Birth year relative to the 1991 recommendation for universal infant HepB vaccination had a strong association with agreement, however, the association was positive for those who reported receiving at least 3 doses and negative for those who reported receiving no doses.
CONCLUSIONS: Although the low PPV in our study could be attributable in part to waning of vaccine-induced anti-HBs over time, national adult HepB vaccination coverage may be lower than previously estimated because national estimates usually depend on self-report of vaccine receipt.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23948014      PMCID: PMC3780730          DOI: 10.2105/AJPH.2013.301313

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  15 in total

1.  Assessment of long-term efficacy of hepatitis B vaccine.

Authors:  M C Ayerbe; A Pérez-Rivilla
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Serologic testing for protection against hepatitis B virus infection among students at a health sciences university in the United States.

Authors:  Philip R Spradling; Roxanne E Williams; Jian Xing; Kenneth Soyemi; Joseph Towers
Journal:  Infect Control Hosp Epidemiol       Date:  2012-05-22       Impact factor: 3.254

3.  Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.

Authors:  J J Ott; G A Stevens; J Groeger; S T Wiersma
Journal:  Vaccine       Date:  2012-01-24       Impact factor: 3.641

Review 4.  Surveillance of hepatitis B: an example of a vaccine preventable disease.

Authors:  M E Ramsay; A A Rushdy; H E Harris
Journal:  Vaccine       Date:  1998-11       Impact factor: 3.641

5.  Persistence of specific antibodies after hepatitis B vaccination.

Authors:  W Jilg; M Schmidt; F Deinhardt
Journal:  J Hepatol       Date:  1988-04       Impact factor: 25.083

6.  Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients.

Authors:  R Mac Donald; L Baken; A Nelson; K L Nichol
Journal:  Am J Prev Med       Date:  1999-04       Impact factor: 5.043

7.  Validation of self-reported pneumococcal vaccination in behavioral risk factor surveillance surveys: experience from the sickness prevention achieved through regional collaboration (SPARC) program.

Authors:  Douglas Shenson; Donna Dimartino; Julie Bolen; Miriam Campbell; Peng-Jun Lu; James A Singleton
Journal:  Vaccine       Date:  2005-01-11       Impact factor: 3.641

8.  The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.

Authors:  Kathleen N Ly; Jian Xing; R Monina Klevens; Ruth B Jiles; John W Ward; Scott D Holmberg
Journal:  Ann Intern Med       Date:  2012-02-21       Impact factor: 25.391

9.  Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers.

Authors:  R C Wood; K L MacDonald; K E White; C W Hedberg; M Hanson; M T Osterholm
Journal:  JAMA       Date:  1993 Dec 22-29       Impact factor: 56.272

10.  Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1991-11-22
View more
  5 in total

1.  Broadening the scope for national database sampling: a critical need.

Authors:  Giang T Nguyen; Chari Cohen; Alison A Evans
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 9.308

2.  Addressing immunization registry population inflation in adolescent immunization rates.

Authors:  Steve G Robison
Journal:  Public Health Rep       Date:  2015 Mar-Apr       Impact factor: 2.792

3.  Attitudes towards latent tuberculosis among physicians in training: the role of BCG vaccination.

Authors:  Franklin Yates; Arun Janakiraman; Anna Headly; Darren R Linkin; Christopher Vinnard
Journal:  J Community Health       Date:  2015-04

4.  Self-reported hepatitis A vaccination as a predictor of hepatitis A virus antibody protection in U.S. adults: National Health and Nutrition Examination Survey 2007-2012.

Authors:  Maxine M Denniston; R Monina Klevens; Ruth B Jiles; Trudy V Murphy
Journal:  Vaccine       Date:  2015-06-24       Impact factor: 3.641

5.  Prevalence of Hepatitis B Vaccination Coverage and Serologic Evidence of Immunity Among US-Born Children and Adolescents From 1999 to 2016.

Authors:  Michael H Le; Yee Hui Yeo; Samuel So; Ed Gane; Ramsey C Cheung; Mindie H Nguyen
Journal:  JAMA Netw Open       Date:  2020-11-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.